Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUOXETINE | 20MG | SOLUTION | Resolved | 2020-02-05 | 2020-09-04 | 105340 |
| APO-LAMOTRIGINE | 100MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105345 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-02-05 | 2020-02-18 | 105348 |
| APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
| APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-02-05 | 2020-06-02 | 105356 |
| APO-TAMOX TAB 10MG | 10MG | TABLET | Resolved | 2020-02-05 | 2020-03-11 | 105359 |
| APO-TRAVOPROST-TIMOP PQ | 0.5% 0.004% | SOLUTION | Resolved | 2020-02-05 | 2020-03-06 | 105364 |
| APO-VARENICLINE | 0.5MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105367 |
| APO-ALLOPURINOL | 100MG | TABLET | Resolved | 2020-02-13 | 2020-04-23 | 105988 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-13 | 2020-04-07 | 105991 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2020-02-13 | 2020-04-14 | 105997 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Resolved | 2020-02-13 | 2020-10-13 | 106000 |
| APO-NAPROXEN | 250MG | TABLET | Resolved | 2020-02-13 | 2020-02-28 | 106003 |
| APO-OLANZAPINE | 5.0MG | TABLET | Resolved | 2020-02-13 | 2020-06-02 | 106006 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2020-02-13 | 2020-06-22 | 106056 |
| APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-02-26 | 2020-04-07 | 107196 |
| APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-02-26 | 2020-03-27 | 107199 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-03-04 | 2020-06-24 | 107690 |
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107693 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
| APO-CELECOXIB | 100MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-11 | 60363 |
| APO-CELECOXIB | 200MG | CAPSULE | Discontinued | 2018-09-07 | 2021-01-21 | 60366 |
| APO-CEPHALEX | 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-21 | 60370 |
| APO-CILAZAPRIL | 1MG | TABLET | To be discontinued | 2018-09-07 | 2018-12-28 | 60373 |
| APO-CIPROFLOX | 250MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60379 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60382 |
| APO-CIPROFLOX | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60385 |